FDA approves 1st gene therapy for genetic hearing loss
Digest more
Regeneron Pharmaceuticals Inc. will offer a gene therapy that restored hearing for a small number of profoundly deaf children at no cost after US regulators approved the treatment.
Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.